• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

几种蒽环类抗生素的细胞药效学。

Cellular pharmocodynamics of several anthrocycline antibiotics.

作者信息

Bachur N R, Steele M, Meriwether W D, Hildebrand R C

出版信息

J Med Chem. 1976 May;19(5):651-4. doi: 10.1021/jm00227a015.

DOI:10.1021/jm00227a015
PMID:1271407
Abstract

Alterations in the C-9 side chain of the anthracycline antibiotics, adriamycin and daunorubicin, have a profound effect on antibiotic uptake and accumulation by cultured L1210 cells. The degree of inhibition of DNA and RNA biosynthesis in the L1210 cells is directly related to the cellular uptake and accumulation of the drug analogues. Polar drug metabolites, daunorubicinol and adriamycinol, retain inhibitory activity against nucleic acid metabolism but have a decreased membrane binding and permeability. Cellular uptake and accumulation of the C-9 analogues are inversely related to drug polarity. We propose that the polarity of the anthracycline analogues contributes heavily to the differences in therapeutic index and in vivo activity through fundamental effects on membrane permeability, metabolism, and macromolecular binding.

摘要

蒽环类抗生素阿霉素和柔红霉素C-9侧链的改变,对培养的L1210细胞摄取和积累抗生素有深远影响。L1210细胞中DNA和RNA生物合成的抑制程度与药物类似物的细胞摄取和积累直接相关。极性药物代谢产物柔红霉醇和阿霉素醇保留了对核酸代谢的抑制活性,但膜结合和通透性降低。C-9类似物的细胞摄取和积累与药物极性呈负相关。我们认为,蒽环类类似物的极性通过对膜通透性、代谢和大分子结合的基本影响,在很大程度上导致了治疗指数和体内活性的差异。

相似文献

1
Cellular pharmocodynamics of several anthrocycline antibiotics.几种蒽环类抗生素的细胞药效学。
J Med Chem. 1976 May;19(5):651-4. doi: 10.1021/jm00227a015.
2
Cellular pharmacology of N,N-dimethyl daunorubicin and N,N-dimethyl adriamycin.N,N-二甲基柔红霉素和N,N-二甲基阿霉素的细胞药理学
Cancer Res. 1980 Jun;40(6):1928-33.
3
Synthesis of 4-demethoxy-11-deoxy-analogs of daunomycin and adriamycin.
J Antibiot (Tokyo). 1980 Dec;33(12):1581-5. doi: 10.7164/antibiotics.33.1581.
4
Inhibition of DNA and RNA metabolism by daunorubicin and adriamycin in L1210 mouse leukemia.柔红霉素和阿霉素对L1210小鼠白血病细胞DNA和RNA代谢的抑制作用
Cancer Res. 1972 Jun;32(6):1137-42.
5
Comparative biochemical studies of adriamycin and daunomycin in leukemic cells.
Cancer Res. 1972 Mar;32(3):511-5.
6
Antitumor anthracycline antibiotics. Structure-activity and structure-cardiotoxicity relationships of rubidazone analogues.
J Med Chem. 1978 Aug;21(8):732-7. doi: 10.1021/jm00206a003.
7
DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.DNA拓扑异构酶II介导的阿霉素和柔红霉素类似物与DNA的相互作用。
Cancer Res. 1989 Nov 1;49(21):5969-78.
8
Baumycins, new antitumor antibiotics related to daunomycin.
J Antibiot (Tokyo). 1977 Jul;30(7):619-21. doi: 10.7164/antibiotics.30.619.
9
Molecular pharmacological differences between carminomycin and its analog, carminomycin-11-methyl ether, and adriamycin.卡米诺霉素及其类似物卡米诺霉素-11-甲醚与阿霉素之间的分子药理学差异。
Cancer Res. 1980 Feb;40(2):387-94.
10
Relationship between effects on nucleic acid synthesis in cell cultures and cytotoxicity of 4-demethoxy derivatives of daunorubicin and adriamycin.柔红霉素和阿霉素的4-去甲氧基衍生物对细胞培养中核酸合成的影响与细胞毒性之间的关系。
Cancer Res. 1977 Dec;37(12):4523-8.

引用本文的文献

1
Targeting OCT3 attenuates doxorubicin-induced cardiac injury.靶向 OCT3 可减轻阿霉素诱导的心脏损伤。
Proc Natl Acad Sci U S A. 2021 Feb 2;118(5). doi: 10.1073/pnas.2020168118.
2
Pharmacokinetics of anthracyclines in dogs: evidence for structure-related body distribution and reduction to their hydroxy metabolites.蒽环类药物在犬体内的药代动力学:与结构相关的体内分布和转化为其羟基代谢物的证据。
Pharm Res. 1984 Jan;1(1):33-8. doi: 10.1023/A:1016378609450.
3
Effect of coenzyme Q10 on the disposition of doxorubicin in rats.辅酶Q10对阿霉素在大鼠体内处置的影响。
Eur J Drug Metab Pharmacokinet. 2002 Jul-Sep;27(3):185-92. doi: 10.1007/BF03190456.
4
Human hepatoma cells rich in P-glycoprotein are sensitive to aclarubicin and resistant to three other anthracyclines.富含P-糖蛋白的人肝癌细胞对阿柔比星敏感,而对其他三种蒽环类药物耐药。
Br J Cancer. 1996 Dec;74(11):1719-29. doi: 10.1038/bjc.1996.621.
5
Epidermal growth factor, phorbol esters, and aurintricarboxylic acid are survival factors for MDA-231 cells exposed to adriamycin.表皮生长因子、佛波酯和金精三羧酸是暴露于阿霉素的MDA - 231细胞的存活因子。
In Vitro Cell Dev Biol Anim. 1994 Dec;30A(12):867-74. doi: 10.1007/BF02639397.
6
Uptake and metabolism of daunorubicin by human leukemia cells.柔红霉素在人白血病细胞中的摄取与代谢
Cancer Chemother Pharmacol. 1982 Dec;10(1):29-32. doi: 10.1007/BF00257233.
7
Cellular pharmacokinetics of aclacinomycin A in cultured L1210 cells. Comparison with daunorubicin and doxorubicin.阿克拉霉素A在培养的L1210细胞中的细胞药代动力学。与柔红霉素和多柔比星的比较。
Cancer Chemother Pharmacol. 1982;8(2):243-9. doi: 10.1007/BF00255491.
8
Individual nuclear uptake patterns for adriamycin and daunomycin in human leukemia and lymphoma cells.阿霉素和柔红霉素在人白血病和淋巴瘤细胞中的个体核摄取模式。
Blut. 1981 Jun;42(6):355-65. doi: 10.1007/BF00996898.
9
Synthesis, biological and biochemical properties of new anthracyclines modified in the aminosugar moiety.氨基糖部分修饰的新型蒽环类药物的合成、生物学及生物化学性质
Cancer Chemother Pharmacol. 1983;10(2):84-9. doi: 10.1007/BF00446215.
10
Uptake, metabolism, and cytotoxicity of doxorubicin in human Ewing's sarcoma and rhabdomyosarcoma cells.阿霉素在人尤文氏肉瘤和横纹肌肉瘤细胞中的摄取、代谢及细胞毒性
Cancer Chemother Pharmacol. 1984;12(1):59-63. doi: 10.1007/BF00255912.